IDSA GUIDELINES Bundle (free trial)

Antimicrobial Prophylaxis in Surgery

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/244264

Contents of this Issue

Navigation

Page 5 of 15

Treatment ÎÎThe antimicrobial agent should be started within 60 minutes prior to surgical incision (up to 120 minutes for vancomycin or fluoroquinolones). Vancomycin should NOT be used for routine perioperative prophylaxis and is less effective for methicillin-sensitive S. aureus (MSSA) than cefazolin. Weight-Based Dosing ÎÎIn theory, using the ideal body weight as the basis for dosing a lipophilic drug (eg, vancomycin) could result in subtherapeutic serum and tissue concentrations, and the use of actual body weight for dosing a hydrophilic drug (eg, an aminoglycoside) could result in excessive serum and tissue concentrations. Note: Body fat percentage is a more sensitive and precise measurement of SSI risk than body mass index. Duration of Prophylaxis ÎÎIf an agent with a short half-life is used (eg, cefazolin, cefoxitin), it should be readministered if the procedure duration exceeds the recommended redosing interval (from the time of initiation of the preoperative dose [see Table 3]). ÎÎReadministration may also be warranted if prolonged or excessive bleeding occurs, or if there are other factors that may shorten the half-life of the prophylactic agent (eg, extensive burns). ÎÎIf antibiotic prophylaxis is continued postoperatively, the duration should be <24 hours regardless of the presence of intravascular catheters or indwelling drains. Note: Limiting the duration of antimicrobial prophylaxis to a single preoperative dose can reduce the risk of Clostridium difficile disease. ÎÎWhen given as a single preoperative dose before incision, antibiotic prophylaxis often does not need to be modified for patients with renal or hepatic dysfunction. Pediatrics ÎÎIn most cases, the data in pediatric patients are limited and have been extrapolated from adult data. Therefore, all pediatric recommendations are based on expert opinion. •  Fluoroquinolones should NOT be routinely used for surgical prophylaxis in pediatric patients because of the potential for toxicity in this population. ÎÎWith few exceptions (eg, aminoglycoside dosages), pediatric dosages should NOT exceed the maximum adult recommended dosages. Note: Generally, if a dosage calculated on a milligram-per-kilogram basis for children weighing >40 kg exceeds the maximum recommended dosage for adults, adult dosages should be used. 4

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Antimicrobial Prophylaxis in Surgery